Trademarkia Logo

Canada

C$
Trademark Search in Canada
ANOCCA

View On IC.GC.CA

ANOCCA
REGISTERED

on 4 Oct 2023

Last Applicant/ Owned by

ANOCCA AB

Östra Vittusgatan 36SE-371 33 Karlskrona

SE

Serial Number

2003298 filed on 16th Jul 2019

Registration Number

TMA1201028 registered on 4th Oct 2023

Registration expiry Date

16th Jul 2029

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

ANOCCA

Trademark usage description

biochemicals, namely for in vitro genetic engineering use; biochemicals, namely for ex vivo genetic engineering use; biochemicals, namely precursors f Read More

Classification Information

Class [001]
Biochemicals, namely for in vitro genetic engineering use; biochemicals, namely for ex vivo genetic engineering use; biochemicals, namely precursors for in vitro genetic engineering use; biochemicals, namely precursors for ex vivo genetic engineering use; biological preparations, namely, for in vitro genetic engineering use; biological preparations, for ex vivo genetic engineering use; biological preparations, precursors for in vitro genetic engineering use; biological preparations, precursors for ex vivo genetic engineering use; biological tissue cultures for use in scientific research; biological preparations in the nature of human tissue and human body fluid, animal tissue and animal body fluid, cultures of microorganisms, tissue and enzymes for scientific and research use in the fields of nucleic acid sequencing, genotyping, diagnosing conditions and diseases, clinical research, drug development and manufacturing, drug development research, laboratory research, agriculture, forensics, food safety, and genetics, not for medical or veterinary purposes; chemical reagents for use in genetic research and genetic identity testing; chemical reagents, namely, for in vitro genetic engineering use; chemical reagents, for ex vivo genetic engineering use; chemical reagents, precursors for in vitro genetic engineering use; chemical reagents, precursors for ex vivo genetic engineering use; diagnostic preparations for medical-scientific research use; diagnostic preparations, namely, for in vitro genetic engineering use; diagnostic preparations, for ex vivo genetic engineering use; diagnostic preparations, precursors for in vitro genetic engineering use; diagnostic preparations, precursors for ex vivo genetic engineering use; immunoassay reagents for medical-scientific research use; immunoassay reagents, namely, for in vitro genetic engineering use; immunoassay reagents, for ex vivo genetic engineering use; immunoassay reagents, precursors for in vitro genetic engineering use; immunoassay reagents, precursors for ex vivo genetic engineering use; immunoassays based on polypeptides for determining immunological profile for scientific research; reagents for use in immunoserology; reagents, namely, for in vitro genetic engineering use; reagents, namely, for ex vivo genetic engineering use; reagents, namely, precursors for in vitro genetic engineering use; reagents, namely, precursors for ex vivo genetic engineering use

Classification kind code

11

Class [005]
Biological preparations for veterinary and medical purposes, namely, for cell therapy; biological preparations for ex vivo gene engineering for medical purposes; biological preparations for cellular therapeutics; biological preparations for cellular therapy; biological preparations for cell therapy; biological preparations for treatment of deceases using cells; biological preparations for medical purposes, namely, for the treatment of cancer, allergies, autoimmune disease and biologic drug rejection; biological preparations for treatment of cancer; biological tissue cultures for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic preparation for veterinary and medical purposes, namely, for detecting cancer, allergies, autoimmune disease and biologic drug rejection; diagnostic preparation for in vitro testing for medical use; diagnostic preparations for clinical laboratory use; diagnostic preparations for medical laboratory use; immunoassay reagents for medical use; immunomodulators; immunostimulants; in vitro diagnostic preparation for medical use; mixed biological preparations for medical purposes for the treatment of cancer, allergies, autoimmune disease and biologic drug rejection; personalized viral antigens for medical diagnosis; personalized tumour antigens for medical diagnosis; personalized tumour vaccines; personalized human vaccines; pharmaceutical compositions with anti-inflammatory properties for the treatment of cancer, allergies, autoimmune disease and biologic drug rejection; pharmaceutical compositions and substances with anti-inflammatory properties for the treatment of cancer, allergies, autoimmune disease and biologic drug rejection; pharmaceutical compositions for the prevention of autoimmune conditions; pharmaceutical compositions for the prevention of autoimmune diseases; pharmaceutical compositions for the prevention of autoimmune disorders; pharmaceutical compositions for the prevention of oncological conditions; pharmaceutical compositions for the prevention of oncological disorders; pharmaceutical compositions for the prevention of oncological diseases; pharmaceutical compositions for the prevention of tumours; pharmaceutical compositions for the treatment of autoimmune conditions; pharmaceutical compositions for the treatment of autoimmune diseases; pharmaceutical compositions for the treatment of autoimmune disorders; pharmaceutical compositions for the treatment of oncological conditions; pharmaceutical compositions for the treatment of oncological diseases; pharmaceutical compositions for the treatment of oncological disorders; pharmaceutical compositions for the treatment of tumours; pharmaceutical preparations for the treatment of cancer, allergies, autoimmune disease and biologic drug rejection; pharmaceutical preparations and substances for the treatment and prevention of cancer, allergies, autoimmune disease and biologic drug rejection; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances with anti-inflammatory properties for the treatment and prevention of cancer, allergies, autoimmune disease and biologic drug rejection; pharmaceutical preparations for activating cellular function for the treatment and prevention of cancer, allergies, autoimmune disease and biologic drug rejection; pharmaceutical preparations for human use in the treatment and prevention of cancer, allergies, autoimmune disease and biologic drug rejection; pharmaceutical preparations for use in immunomodulation therapies; pharmaceutical preparations for medical purposes, namely, the treatment and prevention of cancer, allergies, autoimmune disease and biologic drug rejection; pharmaceutical preparations for prevention of tumours; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the prevention of autoimmune conditions; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the prevention of diseases and disorders of the immune system, namely, autoimmune diseases and disorders and immunologic deficiency syndromes; pharmaceutical preparations for the prevention of oncological conditions; pharmaceutical preparations for the prevention of oncological disorders; pharmaceutical preparations for the prevention of oncological diseases; pharmaceutical preparations for the treatment of autoimmune conditions; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of digestive diseases; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, autoimmune diseases and disorders and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of oncological conditions; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations for the treatment of oncological disorders; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating gastrointestinal disorders; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for treating rheumatological diseases; pharmaceutical preparations for treatment of cancer; pharmaceutical preparations for treatment of digestive system disorders; pharmaceutical preparations for treatment of tumours; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in organ transplantation; pharmaceutical preparations for use in tissue transplantation; preparations for detecting genetic predispositions for medical purposes; prophylactic vaccines for tumors; prophylactic human vaccines; reagents for use in medical genetic testing; tumour antigens for medical diagnosis; tumour prevention vaccines; human vaccines; vaccines for human use; human viral vaccines

Classification kind code

11

Class [009]
Immunostaining instruments for scientific purposes

Classification kind code

11

Class [010]
Apparatus for the diagnosis of autoimmune conditions; apparatus for ex vivo gene engineering; apparatus for cellular therapeutics; apparatus for cell therapy; apparatus for cellular therapy; apparatus for treatment of diseases using cells, namely, medical apparatus for use in cell therapy; apparatus for the diagnosis of autoimmune diseases; apparatus for the diagnosis of autoimmune disorders; apparatus for the diagnosis of inflammatory conditions; apparatus for the diagnosis of inflammatory diseases; apparatus for the diagnosis of inflammatory disorders; apparatus for the diagnosis of oncological conditions; apparatus for the diagnosis of oncological diseases; apparatus for the diagnosis of oncological disorders; apparatus for tumour diagnosis; diagnostic apparatus for medical purposes for testing antigen targets in cancer, infectious disease, allergies, autoimmune disease and biologic drug rejection, and in providing targeting immune receptors for antigen targets in said diseases; diagnostic instruments for medical use for testing blood, urine or tissue specimen for the presence of genes associated with cancer, infectious disease, allergies, autoimmune disease and biologic drug rejection; diagnostic testing apparatus for use in immunoassay procedure (medical); genetic testing apparatus for medical purposes

Classification kind code

11

Class [042]
Research in the field of molecular biology; analysis of human serum for medical research; analysis of human tissues for medical research; biochemical research and analysis; biochemical research in the field of ex vivo gene engineering; biochemical research in the field of cellular therapeutics; biochemical research in the field of cell therapy; biochemical research in the field of cellular therapy; biochemical research in the field of treatment of deceases using cells; biological laboratory services, namely, genetic testing for scientific research purposes; biological clinical research and analysis and medical research in the fields of cancer, infectious disease, allergies, autoimmune disease and biologic drug rejection; biological research and research laboratory services in the fields of cancer, infectious disease, allergies, autoimmune disease and biologic drug rejection; biological research, clinical research and medical research in the fields of cancer, infectious disease, allergies, autoimmune disease and biologic drug rejection; biomedical research services; biotechnology research; blood analysis services for scientific research purposes; cell separation research services; clinical trials; conducting clinical trials; conducting clinical trials for pharmaceutical products; conducting clinical trials in the field of autoimmune disease therapy; conducting clinical trials in the field of cancer therapy; conducting clinical trials in the field of gene therapy; contract research services relating to molecular biology sciences; DNA screening for scientific research purposes; genetic engineering services; genetic engineering services relating to plants; genetic research; genetic testing for scientific research purposes; laboratory scientific services, namely, preparation of biological samples for research purposes and preparation of biological samples for testing and analysis in research laboratories; laboratory research in the field of immunobiology; laboratory research in the field of gene expression, namely, cancer biology; laboratory research services in the field of pharmaceuticals; medical testing laboratory services; laboratory services relating to the production of monoclonal antibodies; medical and pharmacological research services; medical laboratory services for the analysis of blood samples taken from patients; medical research; medical research laboratory services; medical research services; pharmaceutical research and development; pharmaceutical research and development services; pharmaceutical research services; preparation of biological samples for analysis in research laboratories; preparation of biological samples for research purposes; preparation of biological samples for testing and analysis in research laboratories; research and development for the pharmaceutical industry; research and development in the field of biotechnology; research and development in the field of diagnostic preparations; research and development in the field of immunology; research and development in the pharmaceutical and biotechnology fields; research and development of new products for others; research and development of new products for third parties in the field of autoimmunity, cancer and rheumatoid heart disease; research and development of vaccines and medicines; research and development services in the field of antibodies; research and development services in the field of antibody technology; research and development services in the field of immunology; research and development services in the field of microorganisms and cells; research and development services relating to vaccines; research in the field of autoimmune disease; research in the field of gene therapy; research in the field of genetic engineering; research in the field of inflammatory diseases; research in the field of oncology; research laboratories in the field of immunobiology; medical research laboratory services; research of pharmaceuticals; research on the subject of pharmaceuticals; research relating to biotechnology; research relating to medicine; research relating to molecular biology; research relating to pharmaceuticals; research relating to medical science; research and development services in the field of immunology; scientific investigations for medical purposes; scientific research and analysis for medical purposes in the fields of identifying antigen targets in cancer, infectious disease, allergies, autoimmune disease and biologic drug rejection; scientific research and analysis in the field of immunobiology; scientific research and development, namely, medical product development services; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous disease; scientific research in the field of genetics and genetic engineering; scientific research relating to biology; scientific research relating to cellular therapeutics; scientific research relating to genetics; scientific research relating to immuntherapeutics; scientific research relating to prophylactic vaccines; scientific research services in the field of immunobiology; scientific services relating to the isolation and cultivation of human tissue and cells; scientific testing services in the fields of identifying antigen targets in cancer, infectious disease, allergies, autoimmune disease and biologic drug rejection, and in providing targeting immune receptors for antigen targets in said diseases

Classification kind code

11

Class [044]
Blood bank services; medical clinic services; therapy services, namely, T-cell therapy; blood banks; medical clinics; medical clinic services; medical health clinic services; medical care clinics; medical clinics; providing personalized therapy for treating cancer; providing personalized medical services for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases, allergies, and biologic drug rejection; provision of medical services for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases, allergies, and biologic drug rejection; medical testing services relating to the diagnosis and treatment of disease; medical testing services relating to ex vivo gene engineering; medical testing services relating to cellular therapeutics; medical testing services relating to cell therapy; medical testing services relating to cellular therapy; medical services relating to the removal, treatment and processing of human blood; medical services for the treatment of cancer, autoimmune disease and inflammatory disease; medical services for the treatment of conditions of the human body, namely, diabetes, cancer, allergies, autoimmune disease and biologic drug rejection; medical screening services relating to oncological disease, autoimmune disease and inflammatory disease; medical care and analysis services relating to patient treatment; medical diagnostic services; medical health risk assessment services; medical laboratory services for the analysis of samples taken from patients; medical laboratory services for the analysis of blood samples taken from patients; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services relating to the treatment of persons and patients, namely, for diagnosis and treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases, allergies, and biologic drug rejection; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; medical and healthcare services as medical genetic testing; medical services in the field of oncology; genetic testing for medical purposes

Classification kind code

11

Mark Details

Serial Number

2003298

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 13th Oct 2021		Agent Changed
Submitted for opposition 22
on 12th Apr 2021		Search Recorded
Submitted for opposition 20
on 12th Apr 2021		Examiner's First Report
Submitted for opposition 223
on 12th Apr 2021		Total Provisional Refusal
Submitted for opposition 256
on 26th Oct 2020		Notification of Possible Opposition Sent
Submitted for opposition 1
on 27th Dec 2019		Created
Submitted for opposition 31
on 27th Dec 2019		Formalized
Submitted for opposition 257
on 26th Dec 2019		Designation Notification - Madrid Protocol
Submitted for opposition 228
on 16th Jul 2019		International Registration
Submitted for opposition 30
on 16th Jul 2019		Filed